Effects of Virtual Reality-Based Interventions on Neuropathic Pain in Individuals with Spinal Cord Injury: A Meta-Analysis of Randomized Controlled Trials
- Journal
- Journal of pain research (Q1)
- Published
- 17 September 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Chang Liu, Yamei Liu
- PMID
- 42770034
- DOI
- 10.2147/JPR.S644420
Why clinicians should know about it
- Picked for Pharmacology (medical) (top studies of the week, 27 September 2026): VR for neuropathic pain, no PK/PD analysis
Abstract
BACKGROUND: Neuropathic pain is a common and difficult-to-treat complication of spinal cord injury (SCI). Virtual reality (VR)-based interventions have emerged as a non-pharmacological approach to pain modulation, but their efficacy remains uncertain. This meta-analysis evaluated the effect of VR-based interventions on neuropathic pain intensity in individuals with SCI. METHODS: PubMed, Cochrane Library, Embase, Web of Science, Wanfang, and CNKI were searched through June 19, 2026. Randomized controlled trials (RCTs) comparing VR-based interventions with control conditions in adults with SCI-related neuropathic pain were included. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were pooled using a random-effects model accounting for the influence of potential heterogeneity. RESULTS: Ten RCTs involving 317 participants contributed 12 comparisons. VR-based interventions significantly reduced neuropathic pain intensity compared with controls (SMD = -0.50, 95% CI -0.76 to -0.25; p < 0.001; I2 = 27%). Leave-one-out sensitivity analyses confirmed the robustness of the finding (SMD range, -0.42 to -0.60; all p < 0.05). No significant subgroup differences were observed according to study design, mean age, time since SCI, VR intervention type, intervention session pattern, comparator type, pain assessment scale, or risk-of-bias judgment (all p for subgroup differences > 0.05). Meta-regression analyses identified no significant effect modifiers. The certainty of evidence was moderate according to the GRADE system. CONCLUSION: VR-based interventions probably reduce neuropathic pain intensity in individuals with SCI. Further well-designed, adequately powered RCTs are warranted to confirm the magnitude and durability of this effect.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.